[使用从药用植物中获得的化学不稳定的化合物开发功能性化合物]
1Laboratory of Pharmacognosy, Kyoto Pharmaceutical University.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
|January 3, 2024
概括
研究人员开发了一种新方法来从大中合成含硫化合物,显示出对癌症干细胞 (CSC) 的强有力的抗癌活性. 这些新型的皮兰显示出有前途的治疗潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 来自药用植物的含硫和含化合物具有显著的生物活性,包括抗癌性质.
- 这些生物活性化合物的高效合成和分离对于治疗开发至关重要.
- 植物,特别是大,是生物活性硫化合物的来源,如素.
研究的目的:
- 为含硫化合物开发一种新高效的合成策略.
- 为了研究新合成的蒂奥普拉对癌症干细胞 (CSCs) 的抗癌潜力.
主要方法:
- 从Allium植物中分离含硫化合物,特别是四-2-H-difuro[3,2-b:2',3'-c]furan-5(5aH) -one衍生物.
- 使用区域选择性序列双迪尔斯-阿尔德反应快速制备蒂奥普拉.
- 从素 (大成分) 产生烯蛋白作为一个关键的中间体.
主要成果:
- 成功地从Allium植物中分离出特定的含硫 furanone衍生物.
- 设计了一种独特的方法,用于快速合成thiopyranone使用thioacrolein.
- 合成蒂奥普兰对癌症干细胞 (CSCs) 的细胞毒性与 (Z) - ajoene相比或更高.
结论:
- 开发的合成方法提供了一条有效的途径,以获得新型thio.pyranones.
- 合成的蒂奥普拉子显示出作为抗癌剂的显著潜力,特别是对抗癌症干细胞.
- 这项研究强调了天然来源的含硫化合物的治疗前景.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Effects of Chemicals: Overview
1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
208
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
208
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Phase I Oxidative Reactions: Overview
274
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
274


